Federated Hermes
KNSA icon

Federated Hermes’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Federated Hermes’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,292
Closed -$60K – 2255
2021
Q3 		$60K Buy
5,292
+4,939
+1,399% +$64.3K ﹤0.01% 1841
2021
Q2 		$5K Sell
353
-241
-41% -$3.66K ﹤0.01% 2033
2021
Q1 		$11K Hold
594
– – ﹤0.01% 1995
2020
Q4 		$10K Sell
594
-411,839
-100% -$7.23M ﹤0.01% 1985
2020
Q3 		$6.32M Buy
412,433
+16,313
+4% +$306K 0.01% 680
2020
Q2 		$10.1M Buy
396,120
+181,021
+84% +$3.78M 0.03% 539
2020
Q1 		$3.33M Buy
+215,099
New +$3.37M 0.01% 741

Other funds holding KNSA

PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return